Fremont, California, USA; 15 January 2020: LifeSignals Inc., a global leader in the field of wireless biosensor technology through the LifeSignals Processor silicon platform, announced its merger with the connected health assets of Renew Health Limited (Renew), based in Ireland and Singapore. As a result, a new company, LifeSignals Group Inc.(LGI), has been formed and will be led by LifeSignals Inc. CEO and founder Surendar Magar. The LifeSignals Group will incorporate the LifeSignals Inc. business, and its Bangalore-based subsidiary, LifeSignals (India) Private Limited. From Renew, LGI has acquired the UltraLinq cloud-based cardiology PACS platform business and the Zensor™+ cardiac analytics software business.
With its wide-ranging assets, LGI plans to accelerate the global adaptation of clinical-grade wireless biosensors by working with healthcare device OEMs and service providers, thereby improving healthcare delivery to currently underserved populations.
“I am delighted to see this merger come to fruition,” comments Magar. “Combining the assets of both parties brings the scale and resources required for LifeSignals to accelerate its vision of promoting multiparameter clinical-grade wireless biosensors, and replace the billions of “wired” biosensors (e.g. ECG electrodes) that currently dominate the clinical monitoring arena. Overall, the combination of our wireless proprietary smart biosensor technology with the flexible cloud-based analytics will enable patients and healthcare providers to receive potentially life-saving, real-time analysis of health data at a level that did not previously exist.”
Fast-growing Renew Health, co-founded by entrepreneur and visionary Ravinder Sajwan, foresees great potential in this merger. “The Renew Group has long recognized the potential of LifeSignals to lead wireless biosensor adaptation on a global scale due to the unmatched power of its processor technology. Having made major investments in the connected health technologies that are complementary to LifeSignals biosensors, we see it as a natural progression to merge the connected health assets of Renew with LifeSignals Inc., to create LifeSignals Group Inc. Post-merger, Renew will concentrate its resources on the manufacture and global distribution of our unique commercial product portfolio” says CEO Ravinder Sajwan who will serve on the Board of Directors of LifeSignals Group Inc.
For more information:
Product Marketing Manager
LifeSignals Europe Limited
London SE1 2RE
Notes to editors:
LifeSignals (formerly HMicro Inc.) is a venture capital-backed company headquartered in Silicon Valley. Incorporating the patented LifeSignals Processor, a semiconductor platform designed to capture and communicate vital sign physiological data to the cloud, the global team has developed a portfolio of powerful biosensor devices for use within a hospital and home care setting, allowing a higher standard of responsive patient care. Further information can be found at www.lifesignals.com.
Renew Health Limited (Renew), a European division of the global Renew Group, was established in 2014 in Ireland. Based in the IDA business park in Garrycastle in Athlone, Ireland, Renew and its affiliates are committed to delivering exciting healthcare solutions to the market. Its portfolio of products includes BioGlo™ ophthalmic strips, Diagnostic Green’s Indocyanine Green for Injection USP/VERDYE, and IC-Flow™ Imaging System. Further information can be found at http://renewhealthlimite